- be a contributing factor; "make things factor into a companys profitability"
- any of the numbers (or symbols) that form a product when multiplied together
- an independent variable in statistics
- anything that contributes causally to a result; "a number of factors determined the outcome"
- consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
- resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
- an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
- a concept whose truth can be proved; "scientific hypotheses are not facts"
- a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
- a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
- the 16th letter of the Roman alphabet (同)p
- a river in western Thailand; a major tributary of the Chao Phraya (同)Ping River
- (…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
- 〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- Awareness of osteoporosis, risk and protective factors and own diagnostic status: a cross-sectional study.
- Ní Chróinín D, Glavin P, Power D.SourceDepartment of Geriatric Medicine, Beaumont Hospital, Beaumont, Dublin 11, Ireland, firstname.lastname@example.org.
- Archives of osteoporosis.Arch Osteoporos.2013 Dec;8(1-2):117. doi: 10.1007/s11657-012-0117-9. Epub 2013 Jan 8.
- We conducted a cross-sectional study of the understanding on osteoporosis amongst community-dwelling geriatric patients. Patient understanding on the pathology, risk factors and its complications was suboptimal, but better amongst women and persons with diagnosed osteoporosis. Improving patient oste
- PMID 23297105
- Monitoring and modeling treatment of atypical hemolytic uremic syndrome.
- Heinen S, Pluthero FG, van Eimeren VF, Quaggin SE, Licht C.SourceSamuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
- Molecular immunology.Mol Immunol.2013 May;54(1):84-8. doi: 10.1016/j.molimm.2012.10.044. Epub 2012 Dec 3.
- Atypical hemolytic uremic syndrome (aHUS), is mainly present in children, who have high risks of end-stage kidney disease (ESKD), post-transplant recurrence and death. aHUS is linked to defective regulation of the complement alternative pathway (AP), with a prominent cause being mutation/inhibition
- PMID 23220071
- Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages.
- Lee M, Guo JP, McGeer EG, McGeer PL.SourceKinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada.
- Neurobiology of aging.Neurobiol Aging.2013 May;34(5):1451-61. doi: 10.1016/j.neurobiolaging.2012.10.023. Epub 2012 Nov 20.
- Aberrant complement activation is known to exacerbate the pathology in a spectrum of degenerative diseases of aging. We previously reported that aurin tricarboxylic acid (ATA) is an orally effective agent which prevents formation of the membrane attack complex of complement. It inhibits C9 attachmen
- PMID 23177218
- Nanomaterials for Environmental Solar Energy Technologies: Applications & Limitations
- factor P
- 補体、complement-regulatory protein
- actual、actually、in fact、in practice、indeed、practically